Literature DB >> 20600900

Alloreactivity from human viral specific memory T-cells.

L J A D'Orsogna1, D L Roelen, I I N Doxiadis, F H J Claas.   

Abstract

The mechanisms by which alloreactive memory T-cells are generated in non-sensitized individuals have begun to be elucidated. It is generally accepted that a very high level of crossreactivity is an essential feature of the T-cell receptor. Indeed it has recently been shown that alloreactivity from viral specific memory T-cells is far more common than predicted, 45% of viral specific T-cell clones were found to be allo-HLA crossreactive. In this overview the evidence for crossreactive alloresponses from human viral specific memory T-cells is discussed with special emphasis on the unexpected high frequency of these crossreactive responses, the peptide and tissue specificity of the responses, and the mechanistic insights gleaned from the elucidation of the crystal structure of an allo-HLA crossreactive viral specific TCR. The possible implications for clinical solid organ and bone marrow transplantation and tolerance induction will be discussed.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600900     DOI: 10.1016/j.trim.2010.06.008

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  24 in total

1.  Broad spectrum antiviral T cells for viral complications after hematopoietic stem cell transplantation.

Authors:  Britta Maecker-Kolhoff; Britta Eiz-Vesper
Journal:  Ann Transl Med       Date:  2015-05

Review 2.  Alloimmune T cells in transplantation.

Authors:  Susan DeWolf; Megan Sykes
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

Review 3.  Human memory T cells: generation, compartmentalization and homeostasis.

Authors:  Donna L Farber; Naomi A Yudanin; Nicholas P Restifo
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

Review 4.  T cell-mediated hypersensitivity reactions to drugs.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Soren Buus; Imir Metushi; Bjoern Peters; Elizabeth Phillips
Journal:  Annu Rev Med       Date:  2014-10-27       Impact factor: 13.739

5.  Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells.

Authors:  J Joseph Melenhorst; Phillip Scheinberg; Ann Williams; David R Ambrozak; Keyvan Keyvanfar; Melody Smith; J Philip McCoy; Nancy F Hensel; Daniel C Douek; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-06       Impact factor: 5.742

Review 6.  Allo-reactive T cells for the treatment of hematological malignancies.

Authors:  J H F Falkenburg; I Jedema
Journal:  Mol Oncol       Date:  2015-10-24       Impact factor: 6.603

7.  Activation-induced FoxP3 expression regulates cytokine production in conventional T cells stimulated with autologous dendritic cells.

Authors:  Derek J Cavatorta; Hollis N Erb; M Julia Felippe
Journal:  Clin Vaccine Immunol       Date:  2012-08-01

Review 8.  A New Window into the Human Alloresponse.

Authors:  Susan DeWolf; Yufeng Shen; Megan Sykes
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

Review 9.  Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.

Authors:  Katie D White; Wen-Hung Chung; Shuen-Iu Hung; Simon Mallal; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol       Date:  2015-08       Impact factor: 10.793

10.  HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.

Authors:  Mathilde Allard; Pierre Tonnerre; Steven Nedellec; Romain Oger; Alexis Morice; Yannick Guilloux; Elisabeth Houssaint; Béatrice Charreau; Nadine Gervois
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.